Sort
46,585 grants matching “heart failure”
A Digital Twin for Designing Bladder Treatment informed by Bladder Outlet Obstruction Mechanobiology (BOOM)
$646,286Anne Marie Robertson · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
Alemtuzumab and Regulatory T Cells for Heart Transplant Tolerance in Monkeys
$646,234Angus W Thomson · University Of Pittsburgh At Pittsburgh · U01 · FY2011 · AI
Organizational resilience: A novel strategy for improving ICU outcomes
$646,230Deena Kelly Costa · Yale University · R01 · FY2023 · HL
Modulation of Protective RAS-GPCR Pathways in Aortic Disease
$646,151Sadashiva S. Karnik · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · HL
Advancing RAS and RASopathy Therapies
$646,143Marielle Yohe · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Research and Development of Effective Therapies for Patients with Rare Tumors
$646,140Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
Genetically Informed Smoking Cessation Trial
$646,105Li-Shiun Chen · Washington University · R01 · FY2018 · DA
Evaluation of the effectiveness of Ajjmuurur Baamḷe DSMES in the RMI
$645,979Sheldon Riklon · Univ Of Arkansas For Med Scis · R01 · FY2023 · DK
BNP and Neuroimmune Characteristics of CHF & Depression
$645,946Paul J Mills · University Of California, San Diego · R01 · FY2013 · HL
A Phase III Randomized Controlled Trial of Azithromycin for RSV-induced Respiratory Failure in Children
$645,902Michele Kong · University Of Alabama At Birmingham · R01 · FY2024 · HD
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
$645,796Ken Nakamura · J. David Gladstone Institutes · R01 · FY2021 · AG
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
$645,796Ken Nakamura · J. David Gladstone Institutes · R01 · FY2022 · AG
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
$645,796Ken Nakamura · J. David Gladstone Institutes · R01 · FY2023 · AG
Thromboregulatory strategies to prolong xenograft survival.
$645,765Simon C Robson · Beth Israel Deaconess Medical Center · U01 · FY2009 · AI
Disruption of the Cardiac-Coronary Axis as a Mechanism of HFpEF
$645,671Liya Yin · University Of Arizona · R01 · FY2024 · HL
Metabolic Function in Pulmonary Vascular Disease
$645,613John Hughes Newman · Vanderbilt University Medical Center · P01 · FY2018 · HL
Patient Navigators: Secondary Prevention in Underserved Coronary Disease Patients
$645,607Diane M Becker · Johns Hopkins University · R01 · FY2008 · NR
Implementing Effective Smoking Cessation Pharmacotherapy for Hospitalized Smokers with Cardiopulmonary Disease
$645,590Quinn Russell Pack · Baystate Medical Center, Inc. · R01 · FY2025 · HL
Ischemia/Reperfusion injury and Myocardial edema
$645,489Michael Simons · Yale University · R01 · FY2024 · HL
Programming amylin secretion to slow brain aging - an animal model
$645,472Florin Despa · University Of Kentucky · R01 · FY2021 · AG
Physiology of Unloading VA ECMO Trial
$645,394Joseph Edward Tonna · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HL
Advanced Glycation End-Products in Human Myocardium
$645,290Martin M Lewinter · University Of Vermont & St Agric College · R01 · FY2009 · HL
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP).
$645,285Carolyn Harmon Still · Case Western Reserve University · R01 · FY2025 · NR
The state of energy in the right ventricle of patients with pulmonary arterial hypertension
$645,281Arash Kheradvar · University Of California-Irvine · R01 · FY2023 · HL
Volumetric Echocardiographic Particle Image Velocimetry for Grading the Severity of Mitral Valve Regurgitation
$645,279Arash Kheradvar · University Of California-Irvine · R01 · FY2023 · HL